CRBU
Caribou Biosciences Inc
NASDAQ: CRBU · HEALTHCARE · BIOTECHNOLOGY
$1.88
-2.08% today
Updated 2026-04-30
Market cap
$205.84M
P/E ratio
—
P/S ratio
18.45x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$1 – $4
Volume
1.4M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+6.5
Quality
B2.5
Profitability
F6.7
Valuation
B3/9
Piotroski F-Score
Weak
-0.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$11.12
+491.49%
12-Month target
—
—
Intrinsic (DCF)
$2.45
Margin of safety
+35.10%
1 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 89.70% QoQ
+ 35.10% below intrinsic value
+ Debt/equity 0.18x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -0.17 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-21.04M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $13.85M | $34.48M | $9.99M | $11.16M | $11.16M |
| Net income | $-99.42M | $-102.07M | $-149.10M | $-148.13M | $-26.49M |
| EPS | — | — | — | — | $-1.59 |
| Free cash flow | $-97.42M | $-104.90M | $-144.71M | $-112.35M | $-21.04M |
| Profit margin | -717.79% | -296.05% | -1,491.95% | -1,327.40% | — |
Peer comparison
Smart narrative
Caribou Biosciences Inc trades at $1.88. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -0.17, it sits in the distress. TTM revenue stands at $11.16M. Our DCF model estimates intrinsic value at $2.45.
Frequently asked questions
What is Caribou Biosciences Inc's stock price?
Caribou Biosciences Inc (CRBU) trades at $1.88.
Is Caribou Biosciences Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $2.45.
What is the price target of Caribou Biosciences Inc (CRBU)?
The analyst target price is $11.12, representing +491.5% upside from the current price of $1.88.
What is the intrinsic value of Caribou Biosciences Inc (CRBU)?
Based on our DCF model, intrinsic value is $2.45, a +35.1% margin of safety versus $1.88.
What is Caribou Biosciences Inc's revenue?
TTM revenue is $11.16M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-0.17 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio18.45x
ROE-79.00%
Beta2.46
50D MA$1.93
200D MA$1.93
Shares out0.10B
Float0.09B
Short ratio—
Avg volume1.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—